Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Clinical Pharmacology
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Clinical Pharmacology
    Benefit for Early Eptifibatide, Clopidogrel in Patients With Acute Coronary Syndrome: Presented at ACC - (DGDispatch)
    Study Questions Tight Blood Pressure Control in Patients With Diabetes and Coronary Artery Disease: Presented at ACC - (DGDispatch)
    FDA Approves Drug to Treat Hyperammonemia - (DGNews)
    Patients With Child-Pugh Class A Benefit Most From Yttrium-90 Radioembolisation for Liver Cancer: Presented at SIR - (DGDispatch)
    Rosuvastatin Reduces Risk of Death in Patients With CKD, Elevated C-Reactive Protein: Presented at ACC - (DGDispatch)

    News archive

     Recent webcasts/CME - Clinical Pharmacology
    • Translating Guidelines Into Practice: An Expert Roundtable Discussion of Optimal Antiplatelet Therapy in Acute Coronary Syndrome
    • Confronting the Growing Challenge of Preserving Renal Function Following Liver Transplantation
      Type 2 Diabetes in Adolescents
      Tools for Supporting Optimal Fibromyalgia Diagnosis and Treatment: An Update for Primary Care and Managed Care
      Deep Vein Thrombosis in Focus: Expert Perspectives on Reducing the Burden of Venous Thromboembolism

      Webcasts/CME archive

       Recent cases - Clinical Pharmacology
        Intravenous Levosimendan-Norepinephrine Combination During Off-Pump Coronary Artery Bypass Grafting In A Hemodialysis Patient With Severe Myocardial Dysfunction
        Vinblastine, Rituximab And HAART, Treatment Of An HIV -Positive Patient With Multicentric Castleman's Disease
        Interstitial Lung Disease Associated To Erlotinib Treatment: A Case Report
        Daptomycin For Methicillin-Resistant Staphylococcus Epidermidis Native-Valve Endocarditis: A Case Report
        Daptomycin For Treatment Of Methicillin-Resistant Staphylococcus Epidermidis Saphenectomy Wound Infection After Coronary Artery Bypass Graft Operation (CABG): A Case Report

        Cases archive
          




        my personal edition > clinical pharmacology > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Modafinil And D-Amphetamine Action On Electroencephalogram

        A DGReview of :"Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG"
        Psychopharmacology

        03/21/2003
        By Robert Short


        The alertness-promoting effects of modafinil and d-amphetamine involve distinct electroencephalogram activities.

        This is one conclusion resulting from a double-blind, placebo-controlled parallel design study led by Dr Florian Chapotot of the Département des Facteurs Humain, Centre de Recherches du Service de Santé des Armées, La Tronche Cedex, France.

        Thirty three healthy subjects were investigated during 60 hours of sustained wakefulness. The objective of the study was to determine whether modafinil (300 mg), in comparison to the d-amphetamine (20mg) reference psychostimulant and to placebo, interferes with the vigilance regulatory processes reflected in the EEG during waking.

        It was found that one hour after ingestion, both the psychostimulants increased alertness during 10 to 12 hours, independently of the time of administration. At the level of the waking EEG, d-amphetamine attenuated the natural circadian rhythm of the different frequency bands and suppressed the sleep deprivation-related increase in low frequency powers.

        In contrast, modafinil had slight effect on circadian rhythms. Its selective action was characterized by maintenance of the alpha1 EEG power, which under placebo exhibited a homeostatic decrease paralleling that of alertness with a circadian trough at night.

        The researchers said, "These findings demonstrate that the alertness-promoting effects of modafinil and d-amphetamine involve distinct EEG activities and do not reside on the same vigilance regulatory processes. While d-amphetamine inhibits the expression of a sleep-related process, probably through a direct cortical activation masking EEG circadian rhythms, modafinil, through a synchronic effect , preferentially disrupts the homeostatic down-regulation of a waking drive."
        Psychopharmacology 2003;166:127-138. "Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send